ArticleFrontiers in pharmacology2017

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers.

David Monteith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.